BR112022014777A2 - Ensaios de detecção aprimorados - Google Patents

Ensaios de detecção aprimorados

Info

Publication number
BR112022014777A2
BR112022014777A2 BR112022014777A BR112022014777A BR112022014777A2 BR 112022014777 A2 BR112022014777 A2 BR 112022014777A2 BR 112022014777 A BR112022014777 A BR 112022014777A BR 112022014777 A BR112022014777 A BR 112022014777A BR 112022014777 A2 BR112022014777 A2 BR 112022014777A2
Authority
BR
Brazil
Prior art keywords
improved detection
detection tests
assays
tests
improved
Prior art date
Application number
BR112022014777A
Other languages
English (en)
Inventor
Jeremy Blake William
Li Xiang
Katherine Wilson Mary
Marie Coticchia Christine
Ramesh Pradeep
John Manning Brendan
Original Assignee
Sherlock Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sherlock Biosciences Inc filed Critical Sherlock Biosciences Inc
Publication of BR112022014777A2 publication Critical patent/BR112022014777A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C12Q1/683—Hybridisation assays for detection of mutation or polymorphism involving restriction enzymes, e.g. restriction fragment length polymorphism [RFLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases RNAses, DNAses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPRs]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00—Applications; Uses
    • C12N2320/10—Applications; Uses in screening processes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2521/00—Reaction characterised by the enzymatic activity
    • C12Q2521/30—Phosphoric diester hydrolysing, i.e. nuclease
    • C12Q2521/313—Type II endonucleases, i.e. cutting outside recognition site
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2527/00—Reactions demanding special reaction conditions
    • C12Q2527/101—Temperature

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)

Abstract

ENSAIOS DE DETECÇÃO APRIMORADOS. A presente invenção refere-se a ensaios de detecção (por exemplo, diagnósticos) aprimorados que utilizam uma atividade colateral de clivagem de proteína Cas.
BR112022014777A 2020-01-27 2021-01-27 Ensaios de detecção aprimorados BR112022014777A2 (pt)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US202062966527P 2020-01-27 2020-01-27
US202062967536P 2020-01-29 2020-01-29
US202062970159P 2020-02-04 2020-02-04
US202063038710P 2020-06-12 2020-06-12
US202163139267P 2021-01-19 2021-01-19
PCT/US2021/015306 WO2021154866A1 (en) 2020-01-27 2021-01-27 Improved detection assays

Publications (1)

Publication Number Publication Date
BR112022014777A2 true BR112022014777A2 (pt) 2022-09-20

Family

ID=74858746

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022014777A BR112022014777A2 (pt) 2020-01-27 2021-01-27 Ensaios de detecção aprimorados

Country Status (11)

Country Link
US (2) US20230183783A1 (pt)
EP (1) EP4097250A1 (pt)
JP (1) JP2023512985A (pt)
KR (1) KR20220131939A (pt)
AU (1) AU2021212731A1 (pt)
BR (1) BR112022014777A2 (pt)
CA (1) CA3168830A1 (pt)
IL (1) IL295011A (pt)
MX (1) MX2022009212A (pt)
TW (1) TW202142698A (pt)
WO (1) WO2021154866A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020028729A1 (en) 2018-08-01 2020-02-06 Mammoth Biosciences, Inc. Programmable nuclease compositions and methods of use thereof
WO2022150269A1 (en) * 2021-01-07 2022-07-14 Inscripta, Inc. Mad nucleases
KR20230156365A (ko) 2021-03-02 2023-11-14 브레인 바이오테크 아게 메타게놈 유래의 새로운 CRISPR-Cas 뉴클레아제
WO2024005864A1 (en) * 2022-06-30 2024-01-04 Inari Agriculture Technology, Inc. Compositions, systems, and methods for genome editing
WO2024005863A1 (en) * 2022-06-30 2024-01-04 Inari Agriculture Technology, Inc. Compositions, systems, and methods for genome editing
WO2024006552A1 (en) 2022-07-01 2024-01-04 Sherlock Biosciences, Inc. Ambient temperature nucleic acid amplification and detection

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201510296D0 (en) * 2015-06-12 2015-07-29 Univ Wageningen Thermostable CAS9 nucleases
SI3551753T1 (sl) 2016-12-09 2022-09-30 The Broad Institute, Inc. Diagnostika, temelječa na sistemu CRISPR EFFECTOR
CN107488710B (zh) 2017-07-14 2020-09-22 上海吐露港生物科技有限公司 一种Cas蛋白的用途及靶标核酸分子的检测方法和试剂盒
US10253365B1 (en) 2017-11-22 2019-04-09 The Regents Of The University Of California Type V CRISPR/Cas effector proteins for cleaving ssDNAs and detecting target DNAs
JP2021508460A (ja) * 2017-12-22 2021-03-11 ザ・ブロード・インスティテュート・インコーポレイテッド Ｃｒｉｓｐｒエフェクター系に基づくマルチプレックス診断
ES2953541T3 (es) * 2018-03-14 2023-11-14 Arbor Biotechnologies Inc Sistemas y enzimas novedosos de direccionamiento a ADN y ARN de CRISPR
EP3931313A2 (en) * 2019-01-04 2022-01-05 Mammoth Biosciences, Inc. Programmable nuclease improvements and compositions and methods for nucleic acid amplification and detection
US11453907B2 (en) * 2020-03-23 2022-09-27 The Broad Institute, Inc. Crispr effector system based coronavirus diagnostics

Also Published As

Publication number Publication date
AU2021212731A1 (en) 2022-08-25
CA3168830A1 (en) 2021-08-05
JP2023512985A (ja) 2023-03-30
WO2021154866A1 (en) 2021-08-05
US20230272458A1 (en) 2023-08-31
TW202142698A (zh) 2021-11-16
EP4097250A1 (en) 2022-12-07
KR20220131939A (ko) 2022-09-29
IL295011A (en) 2022-09-01
US20230183783A1 (en) 2023-06-15
MX2022009212A (es) 2022-11-09

Similar Documents

Publication Publication Date Title
BR112022014777A2 (pt) Ensaios de detecção aprimorados
BR112022012891A2 (pt) Instrumento cirúrgico compreendendo sistema de detecção
BR112023022592A2 (pt) Cartucho de grampos compreendendo acionadores de grampos e suportes de estabilidade
BR112021021736A2 (pt) Batente de tecido para um instrumento cirúrgico
BR112022012920A2 (pt) Instrumento cirúrgico compreendendo um sistema de ajuste
BR112022012883A2 (pt) Instrumento cirúrgico compreendendo um sistema de detecção de orientação
BR112022012888A2 (pt) Instrumento cirúrgico que compreende um circuito flexível que inclui um sistema de sensor
BR112022012890A2 (pt) Instrumento cirúrgico que compreende um circuito flexível
CY1121872T1 (el) Αξιολογηση, δοκιμασιες και θεραπεια των pkal-μεσολαβουμενων διαταραχων
BR112018010118A2 (pt) inibidores de cxcr2
GT201200271A (es) Proteínas que se unen al tnf-a
CR20140232A (es) Agentes de iarn, composiciones y métodos de uso de los mismos para tratar enfermedades asociadas con transtiretina (ttr)
ES2372709T3 (es) Procedimientos de cribado de proteasas y proteasas identificadas por los mismos.
BR112021018728A2 (pt) Sistema
BRPI0812765B8 (pt) Usos de um anticorpo que se liga à isoforma com domínio-a extra (ed-a) de fibronectina
CO2019002608A2 (es) Biomarcadores de arn para angioedema hereditario
CO2019002607A2 (es) Biomarcadores de metabolitos para enfermedades asociadas con el sistema de activación por contacto
BR112019003785A2 (pt) tabaco resistente a vírus e método de melhoramento para o mesmo
BR112023022615A2 (pt) Instrumento cirúrgico que compreende eletrodos segmentados independentemente ativáveis
BR112018009463A2 (pt) ensaios e métodos para selecionar um regime de tratamento para um sujeito com leucemia
BR112022020780A2 (pt) Composições de trem e usos das mesmas
CL2019002163A1 (es) Cebadores y métodos de detección de virus de peces. (divisional solicitud 201803875).
BR112018003147A2 (pt) anticorpos e testes para detecção de cd37
CO2023017156A2 (es) Anticuerpos anti-sirp-alfa
BR112012025682A2 (pt) vedações de extremidade para uma unidade difusora de aeração